MailerLite
Under review· 4Email marketing, automation, and landing page builder
MailerLite has 4 plans: a free plan, paid plans from $90/year and custom pricing for larger teams. We last read its pricing page on 4 October 2026. We have not recorded a price change.
MailerLite plans and prices
Free
$0
- Subscribers limit — Up to 250
- Monthly emails — 2,500
- User seats — 2
- Support — Community support
- Email campaigns — Send email campaigns
- Automations — 3 automations
- Website — 1 website
- Landing page — 1 landing page
Show all 10 featuresShow fewer
- Digital product or booking — 1
- Signup forms — 3
Growing Business
yearly$90/yr
- monthly$9/mo($9/month)
- Subscribers — Starts at 500, scales up
- Monthly emails — Unlimited
- Users — 3
- Landing pages — Unlimited
- Email campaigns — Yes
- Drag & drop editor — Yes
- Automation — Yes
- 24/7 email support — Yes
Show all 13 featuresShow fewer
- Live chat support — Yes
- MailerLite branding — Removed
- Custom HTML editor — Yes
- Sell digital products — Yes
- Unsubscribe page builder — Yes
Advanced
yearly$180/yr
- monthly$18/mo($18/month)
- Subscribers — Starts at 500, scales up
- Monthly emails — Unlimited
- Users — Unlimited
- Landing pages — Unlimited
- Email campaigns — Yes
- Drag & drop editor — Yes
- Automation — Yes
- 24/7 email support — Yes
Show all 18 featuresShow fewer
- Live chat support — Yes
- MailerLite branding — Removed
- Custom HTML editor — Yes
- Sell digital products — Yes
- Facebook custom audiences — Yes
- Newsletter referral program — Yes
- Dedicated IP — Yes
- AI writing assistant — Yes
- Smart sending — Yes
- Priority support — Yes
Enterprise
Custom
- Subscribers — 100,000+
- Monthly emails — Unlimited
- Users — Unlimited
- Landing pages — Unlimited
- Dedicated account manager — Yes
- Custom onboarding — Yes
- Dedicated IP — Yes
- Priority support — Yes
Show all 11 featuresShow fewer
- Custom newsletter design — Yes
- SLA — Yes
- SSO — Yes
Price history
Last 0 recorded changes
No price changes recorded yet.
Other Marketing products
No confirmed alternatives yet.